Brought to you by 
J&J Pharmaceutical R&D signs oncology deal with Foundation Medicine
07 Dec 2011
Executive Summary
Foundation Medicine Inc. (cancer diagnostics) has agreed to use its clinical cancer genomic test to help identify biomarkers for Johnson & Johnson division Johnson & Johnson Pharmaceutical R&D LLC’s oncology therapy programs.
Deal Industry
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com